Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes or Obesity Without Diabetes”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Not applicableEnrolling By InvitationNCT07736547
What this trial is testing

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

Who this might be right for
Overweight (Without Type 2 Diabetes) With Weight-related ComorbiditiesOverweight (BMI > 25)
Varol TUNALI 80
Testing effectiveness (Phase 2)Study completedNCT05669599
What this trial is testing

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityOverweightType 2 Diabetes Mellitus
Amgen 592
Not applicableStudy completedNCT00834938
What this trial is testing

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

Who this might be right for
DiabetesBariatric SurgeryObesity
University of Campinas, Brazil 24
Early research (Phase 1)Active Not RecruitingNCT07299084
What this trial is testing

Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2OverweightObesity
Eli Lilly and Company 40
Large-scale testing (Phase 3)Study completedNCT04657016
What this trial is testing

Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

Who this might be right for
ObesityOverweight
Eli Lilly and Company 579
Post-approval studies (Phase 4)Looking for participantsNCT07588438
What this trial is testing

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Las Rías Medical Center 160
Large-scale testing (Phase 3)Active Not RecruitingNCT07104500
What this trial is testing

VK2735 for Weight Management Phase 3

Who this might be right for
Weight Loss
Viking Therapeutics, Inc. 4,500
Large-scale testing (Phase 3)Looking for participantsNCT07351045
What this trial is testing

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Who this might be right for
Obesity or Overweight
Hoffmann-La Roche 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06717698
What this trial is testing

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Novo Nordisk A/S 465
Not applicableStudy completedNCT06613711
What this trial is testing

MagDI Italian Study

Who this might be right for
ObesityType 2 Diabetes Mellitus (T2DM)Anastomosis
GT Metabolic Solutions, Inc. 27
Not applicableStudy completedNCT06613724
What this trial is testing

Magnetic Duodeno-Ileal Chile Study

Who this might be right for
ObesityType 2 Diabetes Mellitus (T2DM)
GT Metabolic Solutions, Inc. 10
Not applicableStudy completedNCT06473831
What this trial is testing

MagDI Australia Study

Who this might be right for
ObesityType 2 Diabetes
GT Metabolic Solutions, Inc. 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06643728
What this trial is testing

Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 252
Early research (Phase 1)Study completedNCT06988553
What this trial is testing

A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or OverweightType 2 Diabetes
Eccogene 45
Testing effectiveness (Phase 2)Study completedNCT06737042
What this trial is testing

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Who this might be right for
Obesity and Overweight
Gan and Lee Pharmaceuticals, USA 326
Not applicableNot Yet RecruitingNCT06813170
What this trial is testing

Diet With or Without Metarecod® in Obese Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 180
Early research (Phase 1)Active Not RecruitingNCT05822544
What this trial is testing

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Who this might be right for
Healthy SubjectsObesityType 2 Diabetes
OrsoBio, Inc 564
Early research (Phase 1)Not Yet RecruitingNCT07765511
What this trial is testing

Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Study completedNCT07055516
What this trial is testing

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity and Type 2 Diabetes
Rezera (formerly NodThera Limited) 176
Large-scale testing (Phase 3)Looking for participantsNCT07564414
What this trial is testing

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Who this might be right for
ObesityType 2 Diabetes
Novo Nordisk A/S 2,500
Next Page